TRT and Fertility: How to Preserve Yours
TRT · 8 min read · Updated on May 23, 2026
One of the least-anticipated consequences of starting TRT is the shutdown of sperm production. For an older patient who has finished family planning, that is rarely a problem. For a young man, or anyone considering future fatherhood (immediate or deferred), it is a point to address before the first injection, not after.
This guide explains the mechanism behind spermatogenesis suppression on TRT, the key role of HCG in preserving fertility, the alternatives (clomiphene monotherapy, recombinant FSH), and the reversibility window when fertility was not preserved upfront. For the broader frame, see the pillar TRT protocol guide.
Why TRT shuts down sperm production
Spermatogenesis depends on two converging hormonal signals at the testicular level: LH stimulates Leydig cells to produce intra-testicular testosterone (at concentrations far higher than what circulates in blood), and FSH stimulates Sertoli cells that orchestrate sperm maturation. Both signals are needed: without LH, intra-testicular testosterone collapses and spermatogenesis fails; without FSH, Sertoli cells no longer support maturation.
On TRT, exogenous testosterone triggers central negative feedback: the hypothalamus and then the pituitary shut down GnRH, LH and FSH secretion. The peripheral blood is full of testosterone (that is the goal), but the testes no longer receive any hormonal signal and spermatogenesis goes silent. In most men on TRT for a few months, a semen analysis shows azoospermia (no sperm at all) or severe oligospermia [3].
HCG co-administration: the standard solution
Adding HCG in continuous co-administration with testosterone is the most-used approach to preserve fertility on TRT. HCG mimics LH at the Leydig cell level: it restores intra-testicular testosterone production and keeps enough testicular activity going to support spermatogenesis, even with endogenous FSH suppressed by exogenous testosterone. US TRT clinics that handle younger patients (Defy Medical, Marek Health) build HCG into the default protocol for exactly this reason.
Typical dosing alongside TRT
- 250 to 500 IU two to three times per week, injected subQ. This dose is well below the 'anti-atrophy' doses used on-cycle (500 to 1000 IU twice per week): the point is not to overdrive the testes but to maintain baseline activity [1].
- Frequency spread to track the short half-life (24 to 36 hours): for example Monday/Wednesday/Friday.
- Start: ideally from day one of TRT, especially in a young man.
- Duration: as long as fertility needs to be preserved — often continuous over years.
What HCG actually preserves
- Testicular volume — most men avoid marked atrophy [2].
- Residual sperm production — not always strictly normal, but enough for functional fertility in most patients [2].
- A subjectively better feel on TRT — well-being, libido, sometimes mood.
- Leydig cell sensitivity to endogenous LH, which makes a later restart attempt easier if you ever want to come off TRT.
Alternatives: SERM monotherapy, recombinant FSH
Clomiphene (or enclomiphene) monotherapy
Clomiphene — and its pure isomer enclomiphene, which several US protocols (Maximus and similar) lean on — is a SERM that blocks central estrogen feedback. The result: endogenous GnRH, LH and FSH all rise, which simultaneously stimulates endogenous testosterone production and spermatogenesis. It is an alternative to classic TRT for some patients with secondary hypogonadism who absolutely want to preserve fertility — especially younger men. See clomiphene for the molecule fact sheet.
- Typical dose: 12.5 to 25 mg clomiphene daily, sometimes every other day [4].
- Pros: preserves the whole endogenous LH/FSH signaling and thus spermatogenesis. No injection routine, no suppressive feedback [4].
- Cons: serum stability is lower than with injection-based TRT. Variations are wider and the subjective feel is sometimes less 'smooth'.
- Possible side effects: visual disturbances, mood instability — generally milder at these low doses than at PCT doses (50–100 mg/day).
Recombinant FSH: restarting silent spermatogenesis
When a multi-year TRT was run without HCG and spermatogenesis does not restart after discontinuation, or to optimize a fertility window for an assisted reproduction cycle (IVF, ICSI), recombinant gonadotropins can be used in a short course. These are specialist medications, prescribed and supervised by a reproductive endocrinologist or a fertility-trained urologist.
- Menopur (FSH + LH activity) or Gonal-F (pure recombinant FSH): injectable, doses set by the protocol.
- Paired with HCG to provide the LH signal as needed.
- Duration: typically several months — full spermatogenesis cycles take 70 to 90 days, so meaningful results need time.
- Cost: high, and not every patient recovers spontaneous fertility — referral to ART (IVF/ICSI) may still be needed.
Reversibility window: what the data shows
When TRT was run without HCG, the practical question becomes: if I stop TRT, will spermatogenesis come back? On average the data is reassuring, but individual variability is real.
Typical timelines after discontinuation (no prior HCG)
- First detectable sperm: 3 to 6 months after stopping exogenous testosterone, sometimes longer [5].
- Normal semen analysis (concentration and motility): often 6 to 18 months [5].
- A non-trivial fraction of patients does not regain fully normal fertility within that window, particularly after multi-year TRT without HCG.
Factors that influence reversibility
- TRT duration: the longer the run, the longer the recovery window and the lower the probability of full recovery.
- Age: recovery is faster and more complete in younger men.
- Baseline testicular state: a patient with borderline fertility before TRT (primary hypogonadism, varicocele, prior chemotherapy) has less functional reserve.
- HCG co-administration during TRT: if HCG was maintained throughout, spermatogenesis stayed active and 'recovery' is essentially immediate.
Practical fertility monitoring on TRT
When fertility matters, it gets added to the TRT follow-up calendar — same level as hematocrit or prostate monitoring. A few practical points:
- Baseline semen analysis before TRT, useful to objectify the starting point. Especially if you are choosing between classic TRT + HCG and clomiphene monotherapy: a low baseline can tip the decision.
- Semen analysis 3 to 6 months after start (with HCG co-administration), to confirm spermatogenesis is preserved. Repeat if the dose changes or if family planning gets concrete.
- Sperm cryopreservation before TRT — simple, inexpensive, frees you up. Multi-year storage is available at accredited sperm banks.
- For immediate fatherhood plans, explicit discussion with the endocrinologist: HCG adjustment, temporary TRT pause, or ART with frozen sperm.
Routine TRT bloodwork (LH, FSH, testosterone, estradiol) does not measure fertility — only a semen analysis documents it directly. For integrating fertility checks into the global schedule, see blood test schedule on cycle.
Frequently asked questions
If I start HCG from day one of TRT, will my fertility really be preserved?
In most cases, yes — which is why it has become the standard. With 250 to 500 IU of HCG two to three times per week alongside testosterone, the large majority of men keep normal testicular volume and enough sperm production for functional fertility. A minority will still see semen parameters drop below normal; for them, HCG dose adjustment or a transient addition of recombinant FSH can be discussed with the endocrinologist. A semen analysis at 3 to 6 months after start confirms (or not) whether the protocol is working — that is the only direct measure.
How long does fertility take to recover after stopping TRT?
Without HCG during TRT: count on 3 to 6 months before the first sperm reappear, and 6 to 18 months for a normal semen analysis — when recovery is complete, which is not guaranteed. With HCG maintained throughout: spermatogenesis stayed active, so 'recovery' is essentially immediate. The longer the TRT ran, the slower and more uncertain recovery is without HCG. For a young man with family planning ahead, anticipate with HCG from day one, OR freeze sperm before starting.
Is clomiphene monotherapy better than TRT + HCG for fertility?
Depends on the profile. Clomiphene monotherapy (12.5 to 25 mg/day) preserves the whole endogenous signaling and often gives excellent fertility outcomes, with no injection routine to organize. It is especially well suited to a young man with mild secondary hypogonadism. The downside is that serum testosterone is less stable than with injection-based TRT, and some patients subjectively feel the treatment less well. Classic TRT + HCG gives better serum stability and preserves fertility very well in the large majority, at the cost of two T injections plus two to three HCG injections per week. The call is made case by case with the endocrinologist. For the classic TRT frame, see TRT protocol guide.
Sources
Studies and scientific publications this guide relies on.
- Coviello AD, Matsumoto AM, Bremner WJ, et al. (2005). Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. Journal of Clinical Endocrinology & Metabolism. doi: 10.1210/jc.2004-0802
RCT chez 29 hommes : 250 UI de hCG tous les deux jours, ajoutées à 200 mg/sem de testostérone énanthate, maintiennent la testostérone intratesticulaire proche du baseline (-7 %) vs effondrement (-57 %) sous testostérone seule. Effet dose-réponse mesuré entre 125, 250 et 500 UI tous les deux jours.
- Depenbusch M, von Eckardstein S, Simoni M, et al. (2002). Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone. European Journal of Endocrinology. doi: 10.1530/eje.0.1470617
Étude prospective chez 26 hommes hypogonadotropes en suivi long : l'hCG seule (sans FSH) suffit à maintenir une spermatogenèse établie pour la majorité, démontrant que l'hCG mime fonctionnellement la LH au niveau des cellules de Leydig et permet une production de testostérone intra-testiculaire suffisante pour la spermatogenèse.
- Crosnoe LE, Grober E, Ohl D, et al. (2013). Exogenous testosterone: a preventable cause of male infertility. Translational Andrology and Urology. doi: 10.3978/j.issn.2223-4683.2013.06.01
Revue clinique sur les conséquences de la testostérone exogène sur la spermatogenèse : suppression LH/FSH centrale, chute de la testostérone intra-testiculaire, azoospermie ou oligospermie sévère chez la majorité des patients sous TRT seule. Alternatives détaillées : hCG en co-administration, SERMs (clomiphène) en monothérapie pour préserver la signalisation endogène complète.
- Ramasamy R, Scovell JM, Kovac JR, et al. (2014). Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. Journal of Urology. doi: 10.1016/j.juro.2014.03.089
Étude comparative appariée sur l'âge (n=93 par bras) : citrate de clomiphène (25 à 50 mg/j) vs supplémentation en testostérone chez hommes hypogonadiques symptomatiques. Élévation comparable de la testostérone sérique et satisfaction patient équivalente entre les deux bras, sans suppression de l'axe sous clomiphène.
- Wenker EP, Dupree JM, Langille GM, et al. (2015). The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. Journal of Sexual Medicine. doi: 10.1111/jsm.12890
Série de 49 hommes en azoospermie ou oligospermie sévère après arrêt de la TRT : protocole de relance par hCG (3000 UI tous les deux jours) ± SERM (clomiphène ou tamoxifène) ± FSH recombinante. Récupération d'une spermatogenèse mesurable chez 47 patients sur 49 dans une fenêtre médiane de 4,6 mois.
Guides liés
Track your cycle with real data
Daily journal, 52 compounds, blood work and AI analysis — to apply what you just read and track results cycle after cycle.
Free 5-day trial — no credit card